Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is expanding its remote clinical collaboration and virtual training offerings across its portfolio, building on the IIT * (Innovative Imaging Technologies) Reacts collaborative platform. Leveraging innovative technologies, such as augmented reality, for remote virtual guidance, supervision and training, the platform provides unique interactive tools designed to meet the multi-faceted collaborative needs of healthcare professionals and patients.
“It is vital that we continue to advance our offering to help customers increase first-time-right diagnoses, by integrating innovations and technology that alleviate our customers’ pain points and streamline workflows,” said Bich Le, Business Leader Ultrasound at Philips. “With Reacts’ unique interactive tools we can provide secure expert solutions, and the training and support, needed for physicians to make definitive diagnostic decisions effectively and efficiently. This will enable us to accelerate our commitment to the patients we serve today as well as expanding access to imaging for new users and new use cases. ”
The Reacts platform has already been deployed in more than 80 countries, across various disciplines in both clinical and educational settings. It allows healthcare professionals to interact remotely and dynamically in a wide range of applications, from teleconsultations, secure messaging, remote wound care and tele-ultrasound, to interactive telesurgical assistance and remote procedure supervision.
“Reacts addresses the clear and pressing need for secure remote collaboration and communication between healthcare providers and patients,” said Dr. Yanick Beaulieu, head of Clinical Science for Philips Ultrasound. “By deploying this interactive collaboration platform across Philips’ health technology solutions, we can change patient care models, expand telehealth capabilities, and accelerate technological developments in virtual collaboration globally.”
Since 2018, Reacts is integrated with the Philips’ Lumify point-of-care ultrasound solution, enabling users to share the live ultrasound stream from a Lumify device with a remote colleague on a mobile device, tablet or computer. This allows both parties to simultaneously view the live ultrasound image, as well as the webcam video stream, and provide real time feedback. Lumify with Reacts has proven to be a valuable tool for educational institutions, medical students and resident clinicians, EMS providers with long transit times, disaster relief providers, hospitals with satellite clinics, and clinicians seeking peer-to-peer collaboration for virtual guidance and training.
Lumify with Reacts can provide valuable diagnostic insight for front-line care providers to manage COVID-19-related lung and cardiac complications. Moreover, by enabling remote communication, Reacts reduces the need for physical interaction and can therefore help minimize the risk of virus transmission for medical teams. During the COVID-19 pandemic, Philips has also successfully piloted Reacts to provide case support during image-guided therapy procedures, remotely assisting clinicians as they diagnose and treat patients with coronary artery disease and other cardiovascular diseases. Philips will now further expand Reacts across its Diagnosis & Treatment portfolio.
* IIT Reacts is a wholly owned Philips subsidiary and part of Philips’ Ultrasound business.
Philips expands remote clinical collaboration with Reacts platform
Amsterdam, Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a world leader in health care technology, today announced the expansion of its collaboration and virtual health education offering with the platform collaborative Reacts of TII * (Innovative Imaging Technologies Inc.). Using innovative technologies, such as augmented reality for distance education, supervision and virtual guidance, this platform offers unique interactive tools designed to meet the multiple needs of remote collaboration of healthcare professionals and patients. .
“It is essential that we continue to advance our offer in order to help our customers to increase the reliability of the diagnosis by integrating innovations and technologies which reduce the potential difficulties encountered during examinations and which improve the efficiency of the processes,” said Bich Le, Managing Director of Philips Ultrasound. “With Reacts’ unique interactive tools, we can provide expert, secure solutions, as well as the training and support that physicians need to make final diagnostic decisions effectively. This will allow us to accelerate our commitment to the patients we serve today and to expand access to imagery to new users and new uses. ”
The Reacts platform is used in more than 80 countries in both clinical and educational contexts. It allows healthcare professionals to interact dynamically from a distance for a wide range of applications ranging from teleconsultations, secure messaging, remote wound care and tele-ultrasound, to interactive telesurgical assistance and supervision remote procedures.
“Reacts responds to the growing need for secure collaboration and remote communication between healthcare professionals and patients,” said Dr. Yanick Beaulieu, Director of Clinical Sciences at Philips Ultrasound. “By deploying this interactive collaboration platform through Philips health technology solutions, we can change patient care models, expand telemedicine capabilities and accelerate technological developments in virtual collaboration worldwide. ”
Since 2018, Reacts has been integrated into the Lumify portable ultrasound solutionfrom Philips, allowing users to share the video stream from the Lumify system live, in addition to sharing audio and video from the webcam bi-directionally. This allows a professional performing an ultrasound with the Philips Lumify, from a simple tablet or smartphone, to have access to virtual expertise and assistance in real time, collaborating remotely via Reacts with an expert, little no matter where it is in the world. Lumify with Reacts has proven to be a valuable tool to help clinicians connect and collaborate in real time like never before, without geographic barriers. The solution can notably help optimize patient care by allowing experts to supervise an ultrasound examination virtually for educational establishments,
Lumify with Reacts can provide valuable diagnostic informationprimary care providers to manage COVID-19-related lung and heart complications. In addition, by enabling remote communication, Reacts reduces the need for physical interaction and can therefore help minimize the risk of transmission of the virus for medical teams. During the COVID-19 pandemic, Philips also successfully tested Reacts to provide virtual assistance during imaging guided therapy procedures, helping clinicians remotely diagnose and treat patients with coronary artery disease and other cardiovascular diseases. Philips will now extend the use of Reacts across its entire portfolio of diagnostic and treatment solutions.
* TII is a wholly-owned subsidiary of Philips and is part of the Philips Ultrasound division.
For further information, please contact:
Ben Zwirs
Philips Global Press Office
Tel .: +31 6 15213446
E-mail: ben.zwirs@philips.com
Anna Hogrebe
Philips Global Press Office
Tel .: +1 416 270 6757
E-mail: anna.hogrebe@philips.com
Derya Guzel
Philips Investor Relations
Tel .: +31 20 59 77055
E-mail: derya.guzel@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter .
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading medical technology company dedicated to improving people’s health and achieving better results across the health, life continuum in good health, from prevention to diagnosis, to treatment and home care. Philips relies on cutting-edge technology and in-depth knowledge of the medical community and consumers to offer integrated solutions. Based in the Netherlands, the company is a leader in the field of diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in the field of patient health. consumers and home care. Philips achieved in 2019 a turnover of 19.5 billion euros and employs approximately 81,000 people, with sales and services in more than 100 countries. Information about Philips can be found at the following address:www.philips.com/newscenter .
